Pluripotent stem cells offer the potential for an unlimited source for cell therapy products. However, there is concern regarding the tumorigenicity of these products in humans, mainly due to the possible unintended contamination of undifferentiated cells or transformed cells. Here, we critically review currently available ...
Tumorigenicity Assessment of Cell Therapy Products: The Need for Global Consensus and Points to Consider
Cytotherapy, 2019